CS261697B1 - 1-methyl-5-/n-n-propyl-n-formyl/-amino-6-uracil and process for preparing thereof - Google Patents

1-methyl-5-/n-n-propyl-n-formyl/-amino-6-uracil and process for preparing thereof Download PDF

Info

Publication number
CS261697B1
CS261697B1 CS878787A CS878787A CS261697B1 CS 261697 B1 CS261697 B1 CS 261697B1 CS 878787 A CS878787 A CS 878787A CS 878787 A CS878787 A CS 878787A CS 261697 B1 CS261697 B1 CS 261697B1
Authority
CS
Czechoslovakia
Prior art keywords
methyl
formyl
propyl
amino
aminouracil
Prior art date
Application number
CS878787A
Other languages
Czech (cs)
Slovak (sk)
Other versions
CS878787A1 (en
Inventor
Miroslav Ing Csc Veverka
Ladislav Ing Csc Stibranyi
Jan Ing Csc Jendrichovsky
Jozef Ing Nevydal
Original Assignee
Veverka Miroslav
Stibranyi Ladislav
Jendrichovsky Jan
Nevydal Jozef
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veverka Miroslav, Stibranyi Ladislav, Jendrichovsky Jan, Nevydal Jozef filed Critical Veverka Miroslav
Priority to CS878787A priority Critical patent/CS261697B1/en
Publication of CS878787A1 publication Critical patent/CS878787A1/en
Publication of CS261697B1 publication Critical patent/CS261697B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Predmetom riešenia je 1 -mety 1-5- (N-n- -propyJ-N-formyl)amíno-6-amínouracil a jeho příprava reakciou l-metyl-5-n-propylamíno- -6-amínouracilu s kyselinou mravčou alebo jej reaktívnymi derivátmi. Zlúčenína sa používá ako medziprodukt pre přípravu lieCl- va kardlovaskulárneho systému.The object of the invention is 1-methyl-5- (N-N-propyl-N-formyl) amino-6-aminouracil and its preparation by reacting 1-methyl-5-n-propylamino-6-aminouracil with formic acid or its reactive derivatives . The compound is used as an intermediate for the preparation of the cardiovascular system.

Description

Vynález sa týká nového l-metyl-5-(N-n-propyl-N-formyl) amíno-6-amínour acilu vzorca IThe present invention relates to a novel 1-methyl-5- (N-n-propyl-N-formyl) amino-6-aminoouril of the formula I

CHO . N~ C ř-L- Cl·!'c Cfh lil a sposobu jeho přípravy.CHO. N-C-L-C ° ·? 'Cf c h lil and a process for its preparation.

Zlúčenina vzorca I sa používá ako medziprodukt pre přípravu liečiva kardiovaskulárneho systému. Zlúčenina vzorca I sa připravuje reakciou l-metyl-5-n-propylamíno-6-amínouracilu vzorca II o ' .....The compound of formula I is used as an intermediate for the preparation of a medicament of the cardiovascular system. The compound of formula (I) is prepared by reacting 1-methyl-5-n-propylamino-6-aminouracil of formula (II).

H νΛy nh -ch^c c h3 H ν Λ y nh -ch ^ cch 3

Ako rozpúšťadlo sa m6že použiť voda alebo rozpúšťadlo inertně za podmienok reakcie, ako xylén.As the solvent, water or a solvent inert under the reaction conditions such as xylene can be used.

Podrobnosti jednotlivých spfisobov přípravy sú uvedené v nasledujúcich príkladoch prevedenia, bez toho, že by sa na tieto výlučné obmedzovali.The details of the various methods of preparation are given in the following examples, without being limited to these.

Příklad 1Example 1

61,5 g l-metyl-5-n-propylamíno-6-amínouracilu a 150 ml kyseliny mravčej sa za miešania refluxuje počas 90 minut. Reakčná zmes sa zahusti za vakua a k zvyšku sa přidá 80 mililitrov etanolu, zahřeje sa do varu a přefiltruje. Vysušením sa získá 63,7 g 1-metyl-5- (N-n-propyl-N-formyl )amíno-6-amínouracilu s t. t. 238 až 243 °C.61.5 g of 1-methyl-5-n-propylamino-6-aminouracil and 150 ml of formic acid are refluxed with stirring for 90 minutes. The reaction mixture is concentrated in vacuo and 80 ml of ethanol are added to the residue, heated to boiling and filtered. Drying gave 63.7 g of 1-methyl-5- (N-n-propyl-N-formyl) amino-6-aminouracil, m.p. t. 238 DEG-243 DEG.

Příklad 2Example 2

19,8 g l-metyl-S-n-propylamíno-Ď-amínouracilu sa přidá do 50 ml zmesného anhydridu kyseliny octovej a mravčej a reakčná zmes sa mieša pri teplote 50 °C počas 3,5 hodiny. Spracovaním ako v příklade 1 sa získá 22 g l-metyl-5-(N-n-propyl-N-formyl jamino-6-amínouracilu.19.8 g of 1-methyl-S-n-propylamino-N-aminouracil are added to 50 ml of mixed acetic anhydride and formic anhydride and the reaction mixture is stirred at 50 ° C for 3.5 hours. Working up as in Example 1 gave 22 g of 1-methyl-5- (N-n-propyl-N-formyl jamino-6-aminouracil).

s kyselinou mravčou alebo jej reaktívnymi derivátmi, ako zmesným anhydrldom alebo reaktívnym esterom v organickom alebo vodnoorganickom prostředí pri teplote 15 °C až 150 °C.with formic acid or its reactive derivatives such as mixed anhydride or reactive ester in an organic or aqueous organic medium at a temperature of 15 ° C to 150 ° C.

Postup přípravy zlúčeniny vzorca I podlá vynálezu sa uskutočňuje tak, že sa k 1 mól. dielu zlúčeniny vzorca II přidá 0,8 až 5 mól. dielov kyseliny mravčej alebo jej reaktívneho derivátu, ako zmesného anhydridu alebo reaktívneho esteru. Ako zmesný anhydrid možno použit najmá anhydrid vytvořený s kyselinou octovou, ako reaktívny ester p-nitrofenylester kyseliny mravčej, ako uvádza napr. Mc Omie, J. F. W. (ed) („Protective group in organic chemistry“. New York, Plenům Press 1973). Formylácia s kyselinou mravčou sa móže uskutočniť aj v přítomnosti rozpúšťadla alebo priamo v jej nadbytku.The process for the preparation of the compound of the formula I according to the invention is carried out by adding to 1 mol. of the compound of formula II is added from 0.8 to 5 mol. parts of formic acid or a reactive derivative thereof, such as a mixed anhydride or a reactive ester. The mixed anhydride used may be, in particular, the anhydride formed with acetic acid, such as the reactive ester of p-nitrophenyl formate, e.g. Mc Omie, J. F. W. (ed.) ("Protective group in organic chemistry". New York, Plenum Press 1973). Formic acid formulations can also be carried out in the presence of a solvent or directly in excess.

Příklad 3Example 3

0,95 g l-metyl-5-n-propylamíno-6-ainínouracilu sa refluxuje s 0,85 g p-nitrofenylesteru kyseliny mravčej v 13 ml dimetylformamldu počas 20 minut. Spracovaním ako v příklade 1 sa získá 0,17 g l-metyl-5-(N-n-propyl-N-f ormyl jamíno-6-amínouraciliu.0.95 g of 1-methyl-5-n-propylamino-6-aininouracil is refluxed with 0.85 g of p-nitrophenyl formate in 13 ml of dimethylformamide for 20 minutes. Working up as in Example 1 gave 0.17 g of 1-methyl-5- (N-n-propyl-N-formyl-amino-6-aminouracillus).

Příklad 4Example 4

Analogický postupu v příklade 1 s tým, že sa použije zmes 150 ml kyseliny mravčej a 50 ml. formannidu. Získá sa 60 g l-metyl-5-(N-n-propyl-N-formyl jamíno-6-amínouracilu.Analogous to the procedure of Example 1 except that a mixture of 150 ml formic acid and 50 ml is used. formannidu. 60 g of 1-methyl-5- (N-n-propyl-N-formyl jamino-6-aminouracil) are obtained.

Příklad 5Example 5

Analogický postupu v příklade 1 s tým, že sa použije zmes 150 mil kyseliny mravčej a 15 ml vody. Získá sa 48 g l-metyl-5-(N-n-propyl-N-formyljamíno-6-amínouracilu.Analogous to the procedure of Example 1 except that a mixture of 150 ml of formic acid and 15 ml of water is used. 48 g of 1-methyl-5- (N-n-propyl-N-formyl) amino-6-aminouracil are obtained.

Claims (2)

1. l-metyl-5-(N-n-propyl-N-formyl)ainíno-6-amínouracil vzorca I HN/Y1. 1-Methyl-5- (N-propyl-N-formyl) amino-6-aminouracil of formula I HN / Y O ,ABOUT , CHCHQCHCHQ N CH. C H,~ C ΗΛ (!) r- NH~CH, CH~CHiN CH. CH, ~ (1) r-NH-CH, CH-CHi Ctihonor 3 (II)3 (II) 2. Sposob přípravy zlúčeniny podl'a bodu 1 vzorca I, vyznačený tým, že sa na 1-metyl-5-n-propylamíno-6-amínouracil vzorca II pósobí kyselinou mravčou alebo· jej reaktívnym derivátem, ako· zmesným anhydridom alebo reaktívnym esterom v organickom alebO' vodnoorganickom prostředí pri teplote 15 °C až 150 8C.2. A process for the preparation of a compound according to claim 1, characterized in that 1-methyl-5-n-propylamino-6-aminouracil of formula II is treated with formic acid or a reactive derivative thereof such as a mixed anhydride or reactive ester. in an organic or aqueous-organic medium at a temperature of 15 ° C to 150 ° C.
CS878787A 1987-12-03 1987-12-03 1-methyl-5-/n-n-propyl-n-formyl/-amino-6-uracil and process for preparing thereof CS261697B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS878787A CS261697B1 (en) 1987-12-03 1987-12-03 1-methyl-5-/n-n-propyl-n-formyl/-amino-6-uracil and process for preparing thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS878787A CS261697B1 (en) 1987-12-03 1987-12-03 1-methyl-5-/n-n-propyl-n-formyl/-amino-6-uracil and process for preparing thereof

Publications (2)

Publication Number Publication Date
CS878787A1 CS878787A1 (en) 1988-07-15
CS261697B1 true CS261697B1 (en) 1989-02-10

Family

ID=5438908

Family Applications (1)

Application Number Title Priority Date Filing Date
CS878787A CS261697B1 (en) 1987-12-03 1987-12-03 1-methyl-5-/n-n-propyl-n-formyl/-amino-6-uracil and process for preparing thereof

Country Status (1)

Country Link
CS (1) CS261697B1 (en)

Also Published As

Publication number Publication date
CS878787A1 (en) 1988-07-15

Similar Documents

Publication Publication Date Title
US4130564A (en) Process for the manufacture of maleimides
CS261697B1 (en) 1-methyl-5-/n-n-propyl-n-formyl/-amino-6-uracil and process for preparing thereof
US4140862A (en) Salts of diamines and tetrahalophthalates
JPH01216976A (en) Production of 1-hydroxyalkyl-5-nitroimidazole
US4585875A (en) Process for preparing 4,4-bis-benz-ox(-thi,-imid)-azol-2-yl-stilbenes
US4925944A (en) Process for the preparation of o-carboxypyridyl- and o-carboxyquinolylimidazolinones
US4182880A (en) 1,8-Naphthyridine compounds and process for preparing the same
US4036841A (en) Indolo[2,3α]quinolizine derivatives
US4160828A (en) Analgesic phosphinyl compounds and compositions
DE69027300T2 (en) 1,2-DIHYDRO-2-OXOQUINOXALINE DERIVATIVES, THEIR PRODUCTION AND USE IN THERAPY
US4841092A (en) Preparation of tris(2-cyanoethyl)amine
JPH05501579A (en) Method for producing quinophthalone derivatives
GB2092130A (en) 4-Oximino-1,2,3,4- tetrahydroquinoline Derivatives
EP0393109B1 (en) Novel 2,3-thiomorpholinedione-2-oxime derivatives, pharmaceutical compositions containing them and process for preparing same
US4017533A (en) Diaminomaleonitrile derivatives and processes for preparing the same
US2899440A (en) Process for the manufacture of
JPH062747B2 (en) Process for producing 2-alkyl-4,5-dihydroxymethylimidazole
CA1110247A (en) Process for preparing certain ethyleneglycol diesters
US4552967A (en) Process for the synthesis of intermediates in the preparation of diaminopyridines
US4219650A (en) Process for the preparation of pyrrolidonecarboxylic acid/metal/amine complexes
CA1162543A (en) Process for the preparation of apovincaminic acid esters
EP0315902B1 (en) Bis-indolyl ethylene aldehydes
SU508057A1 (en) Tropic esters of 5-arylfuran-2-carboxylic acids, or their hydrochlorides, exhibiting local anesthetic activity, and method for their preparation
KR810001131B1 (en) Process for preparing 3-piperidone derivatives
JPS6160673A (en) Preparation of guanidinothiazole derivative